Profiel
Christopher Benecchi is Chief Operating Officer at Inventiva SA since 2026.
Formerly, Mr. Benecchi was Chief Executive Officer at Motric Bio, Inc. Mr. Benecchi was Vice President & Global Head-Commercial Excellence at Alexion Pharmaceuticals, Inc. from 2019 to 2021.
Mr. Benecchi was Global Launch Head-Commercial & Medical Affairs at UCB, Inc. from 2018 to 2019.
Mr. Benecchi was COO, Principal Financial & Accounting Officer at SAGE Therapeutics, Inc. from 2024 to 2025.
Mr. Benecchi earned an MBA from Duke University and completed undergraduate studies at Colby College.
Actieve functies van Christopher Benecchi
| Bedrijven | Functie | Begin |
|---|---|---|
| INVENTIVA | Operationeel Directeur | 31-08-2026 |
Eerdere bekende functies van Christopher Benecchi
| Bedrijven | Functie | Einde |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Financieel Directeur/CFO | 01-08-2025 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-09-2021 |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Provides financial services | Corporate Officer/Principal | 01-08-2019 |
Opleiding van Christopher Benecchi
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Colby College
Colby College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Provides financial services | Finance |
SAGE Therapeutics, Inc.
SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
Inventiva SA
Inventiva SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops oral small molecule therapies for the treatment of MASH and other diseases | Health Technology |
















